DE60111494D1 - Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung - Google Patents

Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung

Info

Publication number
DE60111494D1
DE60111494D1 DE60111494T DE60111494T DE60111494D1 DE 60111494 D1 DE60111494 D1 DE 60111494D1 DE 60111494 T DE60111494 T DE 60111494T DE 60111494 T DE60111494 T DE 60111494T DE 60111494 D1 DE60111494 D1 DE 60111494D1
Authority
DE
Germany
Prior art keywords
vomeropherin
increasing
administration
wax therapy
effective alarm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111494T
Other languages
English (en)
Other versions
DE60111494T2 (de
Inventor
L Berliner
Louis Monti
L Jennings-White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pherin Pharmaceuticals Inc
Original Assignee
Pherin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharmaceuticals Inc filed Critical Pherin Pharmaceuticals Inc
Publication of DE60111494D1 publication Critical patent/DE60111494D1/de
Application granted granted Critical
Publication of DE60111494T2 publication Critical patent/DE60111494T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Emergency Alarm Devices (AREA)
DE60111494T 2000-02-04 2001-02-02 Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung Expired - Lifetime DE60111494T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US498830 2000-02-04
US09/498,830 US6544971B1 (en) 2000-02-04 2000-02-04 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
PCT/US2001/003572 WO2001056577A1 (en) 2000-02-04 2001-02-02 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices

Publications (2)

Publication Number Publication Date
DE60111494D1 true DE60111494D1 (de) 2005-07-21
DE60111494T2 DE60111494T2 (de) 2006-05-18

Family

ID=23982680

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111494T Expired - Lifetime DE60111494T2 (de) 2000-02-04 2001-02-02 Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung

Country Status (12)

Country Link
US (1) US6544971B1 (de)
EP (1) EP1251856B1 (de)
JP (1) JP2003523329A (de)
KR (1) KR20020073570A (de)
CN (1) CN1418101A (de)
AT (1) ATE297738T1 (de)
AU (1) AU3329401A (de)
BR (1) BR0108004A (de)
CA (1) CA2397790A1 (de)
DE (1) DE60111494T2 (de)
MX (1) MXPA02007496A (de)
WO (1) WO2001056577A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7283427B1 (en) 2005-12-08 2007-10-16 James Thomas Stevens Machine for waking a sleeper
DE102007022916A1 (de) * 2007-05-14 2008-11-20 Henkel Ag & Co. Kgaa Pheromonhaltige kosmetische Mittel
DE102012009570A1 (de) * 2012-05-09 2013-11-14 Naum Goldstein Komposition für nasale Anwendung
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU693077B2 (en) 1993-06-15 1998-06-25 Pherin Pharmaceuticals, Inc. Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PL183582B1 (pl) 1993-06-15 2002-06-28 Pherin Pharmaceuticals Kompozycja farmaceutyczna do donosowego podawania ludziom,zawierająca związek steroidowy oraz związek steroidowy

Also Published As

Publication number Publication date
CN1418101A (zh) 2003-05-14
JP2003523329A (ja) 2003-08-05
US6544971B1 (en) 2003-04-08
MXPA02007496A (es) 2002-12-13
AU3329401A (en) 2001-08-14
EP1251856A1 (de) 2002-10-30
KR20020073570A (ko) 2002-09-27
EP1251856B1 (de) 2005-06-15
CA2397790A1 (en) 2001-08-09
DE60111494T2 (de) 2006-05-18
BR0108004A (pt) 2004-01-06
ATE297738T1 (de) 2005-07-15
WO2001056577A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
DE69811378D1 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
DE50006156D1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
DE69017302D1 (de) Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten.
FI960727A (fi) Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
ATE510542T1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DK0776202T3 (da) Liposomalt indkapslet taxol, dets fremstilling af dets anvendelse
DE602004031462D1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
ATE527010T1 (de) Vorrichtung zur verabreichung von co
DK0817770T3 (da) Nonpeptider som tachykininantagonister
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
ATE446751T1 (de) Verwendung von methylnaltrexon zur behandlung von immunsuppression
DE60111494D1 (de) Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
DK0391185T3 (da) 1,8-Naphthyridiner
ATE216587T1 (de) Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments
TR200003502T2 (tr) Bir Piperidin Maddesi P Antagonistini İçeren Mikroemülsiyon Prekonsantratları
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
PT862454E (pt) Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition